Literature DB >> 17206709

Oral biopsies from patients with orofacial granulomatosis with histology resembling Crohn's disease have a prominent Th1 environment.

Jona Freysdottir1, Sha Zhang, Wanninayake M Tilakaratne, Farida Fortune.   

Abstract

BACKGROUND: Orofacial granulomatosis (OFG) is an idiopathic inflammatory disorder of children and young adults whose clinical symptoms include swelling of the lips or face, mucosal nodularity (cobblestoning), mucosal tags, hyperplasia of the gingivae, and aphthous oral ulcers. Whether some OFG patients with clinical and histological characteristics resembling Crohn's disease (CD) are a special group (oral CD) or true CD patients with symptoms reaching all the way to the oral mucosa remains to be determined.
METHODS: In this study oral biopsies from 10 patients with OFG were analyzed for the presence of T cells, T-cell subsets, B cells, and macrophages, as well as cytokines (IL-4, IL-10, IFN-gamma, IL-12, and TNF-alpha), chemokines (RANTES and MIP-1alpha), and chemokine receptors (CCR3, CCR5, and CXCR3). For comparison, oral tissues from 7 patients with other granulomatous diseases were included.
RESULTS: Compared with the non-OFG group, the OFG group had raised levels of CD4(+) T cells, IFN-gamma, IL-10, and RANTES but reduced levels of CD68(+) macrophages outside the granulomas, whereas within the granulomas the levels of CD3(+) and CD4(+) T cells and of IFN-gamma were raised, but the levels of IL-4 were decreased. These data are indicative of a Th1 environment within the oral OFG tissues, which resembles that already observed in gut CD tissues.
CONCLUSIONS: Therefore, it can be concluded that some OFG patients have both histopathological and immunopathological features that resemble those observed in CD patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17206709     DOI: 10.1002/ibd.20023

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  8 in total

1.  Idiopathic orofacial granulomatosis - a diagnostic and treatment challenge.

Authors:  R Vishwanath Rangdhol; N Madhulika; A Dany; S Jeelani; G S Asokan
Journal:  J Clin Diagn Res       Date:  2014-11-20

2.  A 30-year follow-up study of patients with Melkersson-Rosenthal syndrome shows an association to inflammatory bowel disease.

Authors:  Anu Haaramo; Kaija-Leena Kolho; Anne Pitkäranta; Mervi Kanerva
Journal:  Ann Med       Date:  2019-04-13       Impact factor: 4.709

3.  Immunophenotype in orofacial granulomatosis with and without Crohn's disease.

Authors:  Gita Gale; Sofia Ostman; Robert Saalman; Esbjörn Telemo; Mats Jontell; Bengt Hasséus
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-11-01

4.  Oral Crohn's disease.

Authors:  Bn Padmavathi; Smriti Sharma; Madhusudan Astekar; Y Rajan; Gv Sowmya
Journal:  J Oral Maxillofac Pathol       Date:  2014-09

5.  Combination of recurrent oral aphthae and dry eye syndrome may constitute an independent risk factor for oral cavity cancer in elderly women.

Authors:  Lei Qin; Yi-Wei Kao; Yueh-Lung Lin; Bou-Yue Peng; Win-Ping Deng; Tsung-Ming Chen; Kuan-Chou Lin; Kevin Sheng-Po Yuan; Alexander Th Wu; Ben-Chang Shia; Szu-Yuan Wu
Journal:  Cancer Manag Res       Date:  2018-09-05       Impact factor: 3.989

Review 6.  Emerging Topical and Systemic JAK Inhibitors in Dermatology.

Authors:  Farzan Solimani; Katharina Meier; Kamran Ghoreschi
Journal:  Front Immunol       Date:  2019-12-03       Impact factor: 7.561

7.  Orofacial granulomatosis: a questionnaire study among Norwegian dental clinicians.

Authors:  A B Skaare; E S Hovden; B B Herlofson; T M Søland
Journal:  Eur Arch Paediatr Dent       Date:  2020-02-04

8.  Recurrent aphthous stomatitis may be a precursor or risk factor for specific cancers: A case-control frequency-matched study.

Authors:  Lei Qin; Yi-Wei Kao; Yueh-Lung Lin; Bou-Yue Peng; Win-Ping Deng; Tsung-Ming Chen; Kuan-Chou Lin; Kevin Sheng-Po Yuan; Alexander T H Wu; Ben-Chang Shia; Szu-Yuan Wu
Journal:  Cancer Med       Date:  2018-07-15       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.